来凯医药-B(02105)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02105 来凯医药-B

交易中 02-10 13:48:00

12.630

+0.310

+2.52%

最高13.110	最低12.400	成交量94.20万
今开12.490	昨收12.320	日振幅5.76%
总市值56.33亿	流通市值56.33亿	总股本4.46亿
成交额1,205万	换手率0.21%	流通股本4.46亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02105","market":"HK","secType":"STK","nameCN":"来凯医药-B","latestPrice":12.63,"timestamp":1770702437651,"preClose":12.32,"halted":0,"volume":942000,"delay":0,"changeRate":0.025162337662337702,"floatShares":446000000,"shares":446000000,"eps":-0.711066,"marketStatus":"交易中","change":0.31,"latestTime":"02-10 13:48:00","open":12.49,"high":13.11,"low":12.4,"amount":12046246,"amplitude":0.05763,"askPrice":12.7,"askSize":1500,"bidPrice":12.63,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.59,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770711000000},"marketStatusCode":2,"adr":0,"listingDate":1687968000000,"exchange":"SEHK","adjPreClose":12.32,"openAndCloseTimeList":[[1770687000000,1770696000000],[1770699600000,1770710400000]],"volumeRatio":0.912928,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02105","defaultTab":"news","newsList":[{"id":"2610697551","title":"来凯医药-B盘中异动 股价大涨5.11%报12.950港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610697551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610697551?lang=zh_cn&edition=full","pubTime":"2026-02-10 10:38","pubTimestamp":1770691099,"startTime":"0","endTime":"0","summary":"2026年02月10日早盘10时38分，来凯医药-B股票出现异动，股价大幅拉升5.11%。截至发稿，该股报12.950港元/股，成交量53.8万股，换手率0.12%，振幅4.46%。资金方面，该股资金流入513.259万港元，流出103.209万港元。来凯医药-B股票所在的生物技术行业中，整体涨幅为2.76%。其相关个股中，宜明昂科-B、荣昌生物、歌礼制药-B涨幅较大，振幅较大的相关个股有帝王国际投资、泰格医药、旺山旺水-B，振幅分别为10.91%、7.71%、7.37%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010381997a59056&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010381997a59056&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2610693390","title":"每日卖空追踪 | 来凯医药-B 02月09日卖空量成交7.45万股，卖空比例为3.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610693390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610693390?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:30","pubTimestamp":1770625827,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间02月09日，跌0.65%，卖空量成交7.45万股，较上一交易日减少81.12%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163752a6e54fc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163752a6e54fc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2609040567","title":"每日卖空追踪 | 来凯医药-B 02月06日卖空量成交15.35万股，卖空比例为5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609040567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609040567?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:30","pubTimestamp":1770366629,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间02月06日，跌8.22%，卖空量成交15.35万股，较上一交易日减少9.44%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163426a6dac2e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163426a6dac2e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2609670965","title":"来凯医药-B02月06日主力净流出176.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2609670965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609670965?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:15","pubTimestamp":1770365751,"startTime":"0","endTime":"0","summary":"02月06日, 来凯医药-B股价跌8.22%，报收12.40元，成交金额3666.1万元，换手率0.64%，振幅8.44%，量比1.84。来凯医药-B今日主力资金净流出176.5万元，上一交易日主力净流入37.0万元。该股近5个交易日下跌9.49%，主力资金累计净流出390.6万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入1840.6万元，其中净流入天数为12日。该股主力净额占比0.03%，港股市场排名2591/2715。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206162047a483bd71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206162047a483bd71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"1128659977","title":"来凯医药（2105）2026年1月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1128659977","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128659977?lang=zh_cn&edition=full","pubTime":"2026-02-05 17:11","pubTimestamp":1770282702,"startTime":"0","endTime":"0","summary":"来凯医药有限公司于2026年2月5日发布截至2026年1月31日止月份的股份变动月报表。公告显示，公司本月注册股本及已发行股份总数均保持不变。来凯医药本月注册股本仍为5,000,000,000股普通股，面值每股0.00001美元，注册股本总额维持在50,000美元。首次公开发售前购股权计划与首次公开发售后购股权计划均无新增行使记录。公告显示，本次月度股份变动事项符合上市规则及相关法律规定，并已获得董事会正式授权审批。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105"],"gpt_icon":0},{"id":"2608033801","title":"每日卖空追踪 | 来凯医药-B 02月03日卖空量成交10.05万股，卖空比例为9.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608033801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608033801?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:30","pubTimestamp":1770107427,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间02月03日，涨1.81%，卖空量成交10.05万股，较上一交易日减少49.88%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203163443a6cdb7b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203163443a6cdb7b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2608380105","title":"来凯医药-B02月03日主力净流入164.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2608380105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608380105?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:15","pubTimestamp":1770106528,"startTime":"0","endTime":"0","summary":"02月03日, 来凯医药-B股价涨1.81%，报收13.47元，成交金额1405.9万元，换手率0.23%，振幅4.46%，量比0.65。来凯医药-B今日主力资金净流入164.9万元，上一交易日主力净流出278.7万元。该股近5个交易日下跌7.56%，主力资金累计净流入68.2万元；近20日主力资金累计净流入1512.1万元，其中净流入天数为12日。该股主力净额占比0.03%，港股市场排名225/2709。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161705a6cda280&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161705a6cda280&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2607721894","title":"每日卖空追踪 | 来凯医药-B 01月28日卖空量成交8.75万股，卖空比例为9.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607721894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607721894?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:30","pubTimestamp":1769589027,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间01月28日，跌0.55%，卖空量成交8.75万股，较上一交易日减少63.24%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164750a6b6851d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164750a6b6851d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2606007275","title":"每日卖空追踪 | 来凯医药-B 01月26日卖空量成交45.45万股，卖空比例为9.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606007275","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606007275?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:30","pubTimestamp":1769416228,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间01月26日，跌7.03%，卖空量成交45.45万股，较上一交易日增加23.17%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126163854a456c6fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126163854a456c6fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2606942072","title":"来凯医药-B盘中异动 早盘股价大跌5.27%报15.100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606942072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606942072?lang=zh_cn&edition=full","pubTime":"2026-01-26 09:35","pubTimestamp":1769391304,"startTime":"0","endTime":"0","summary":"2026年01月26日早盘09时35分，来凯医药-B股票出现波动，股价大幅跳水5.27%。截至发稿，该股报15.100港元/股，成交量24.55万股，换手率0.05%，振幅9.41%。资金方面，该股资金流入244.357万港元，流出92.026万港元。来凯医药-B股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，中生北控生物科技、维亚生物、君实生物涨幅较大，振幅较大的相关个股有维亚生物、来凯医药-B、方达控股，振幅分别为15.35%、9.41%、7.00%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126093504953e4665&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126093504953e4665&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2605477362","title":"每日卖空追踪 | 来凯医药-B 01月23日卖空量成交31.65万股，卖空比例为2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605477362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605477362?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:30","pubTimestamp":1769157027,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间01月23日，涨12.57%，卖空量成交31.65万股，较上一交易日增加102.88%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123163927a44d9fa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123163927a44d9fa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2605477365","title":"来凯医药-B01月23日主力净流入99.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2605477365","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605477365?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:15","pubTimestamp":1769156143,"startTime":"0","endTime":"0","summary":"01月23日, 来凯医药-B股价涨12.57%，报收15.94元，成交金额1.7亿元，换手率2.43%，振幅16.74%，量比4.33。来凯医药-B今日主力资金净流入99.3万元，上一交易日主力净流出107.6万元。该股近5个交易日上涨9.66%，主力资金累计净流入753.3万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入756.9万元，其中净流入天数为9日。该股主力净额占比0.01%，港股市场排名354/2709。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123162047a44d8983&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123162047a44d8983&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2605683440","title":"港股异动｜来凯医药大涨超18%，旗下新药LAE118临床试验申请获美国FDA受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2605683440","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605683440?lang=zh_cn&edition=full","pubTime":"2026-01-23 10:57","pubTimestamp":1769137022,"startTime":"0","endTime":"0","summary":"来凯医药(2105.HK)放量大涨超18%，最高触及16.72港元，创逾一个月新高。消息面上，来凯医药公布，旗下有望治疗PIK3CA类乳腺癌突变实体瘤的新药LAE118，已获美国药监局(FDA)受理临床试验申请。据介绍，LAE118是一种新型PI3Kα泛突变选择性抑制剂，为针对PIK3CA突变实体瘤的新型疗法。公司将与监管机构紧密合作以完成相关申请。凭借其在临床开发和对外授权LAE002(afuresertib)的良好及已验证的实绩，公司致力于为需要新型治疗方案的癌症患者提供这种精准治疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260123/31966645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1610","02105","BK1161"],"gpt_icon":0},{"id":"2604918481","title":"每日卖空追踪 | 来凯医药-B 01月19日卖空量成交14.5万股，卖空比例为5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604918481","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604918481?lang=zh_cn&edition=full","pubTime":"2026-01-19 16:30","pubTimestamp":1768811427,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间01月19日，跌3.79%，卖空量成交14.5万股，较上一交易日减少29.44%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119164034a43c2526&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119164034a43c2526&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2604874184","title":"政策催化叠加价值兑现 国产创新药领域开启景气周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2604874184","media":"制药网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604874184?lang=zh_cn&edition=full","pubTime":"2026-01-19 13:44","pubTimestamp":1768801475,"startTime":"0","endTime":"0","summary":"多款国产新药密集获批、BD交易规模放量、海外临床进展提速，多重积极信号凸显行业高景气度，国产创新药正从研发驱动迈向价值兑现的关键阶段。根据数据统计，2026年开年以来，已有多款国产新药相继获批上市。进入2026年，国内创新药BD授权规模仍持续放量、合作模式升级。近年来，政策支持为行业发展保驾护航，叠加研发实力积累与商业化能力提升，国产创新药正迎来黄金发展时期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119134953a43b8e59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119134953a43b8e59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","BK1161","02105","06978","06887","09995","BK1574"],"gpt_icon":0},{"id":"2603952893","title":"来凯医药-B(02105.HK)午后一度涨近5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603952893","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603952893?lang=zh_cn&edition=full","pubTime":"2026-01-16 13:57","pubTimestamp":1768543026,"startTime":"0","endTime":"0","summary":"每经AI快讯，来凯医药-B(02105.HK)午后一度涨近5%，截至发稿涨3.04%，报13.88港元，成交额1991.83万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601163621775579.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601163621775579.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2603954118","title":"港股异动 | 来凯医药-B(02105)午后涨近5% 美国FDA受理LAE118新药临床试验申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2603954118","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603954118?lang=zh_cn&edition=full","pubTime":"2026-01-16 13:38","pubTimestamp":1768541928,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，来凯医药-B(02105)午后涨近5%，截至发稿，涨3.04%，报13.88港元，成交额1991.83万港元。消息面上，来凯医药公布，旗下有望治疗PIK3CA类乳腺癌突变实体瘤的新药LAE118，已获美国药监局(FDA)受理临床试验申请。公司介绍指LAE118是一种新型PI3Kα泛突变选择性抑制剂，为针对PIK3CA突变实体瘤的新型疗法。公告称，公司将与监管机构紧密合作以完成相关申请。凭借其在临床开发和对外授权LAE002(afuresertib)的良好及已验证的实绩，公司致力于为需要新型治疗方案的癌症患者提供这种精准治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393732.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2603214675","title":"来凯医药-B01月14日主力净流入436.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2603214675","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603214675?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:15","pubTimestamp":1768378523,"startTime":"0","endTime":"0","summary":"01月14日, 来凯医药-B股价涨4.91%，报收14.10元，成交金额6331.7万元，换手率1.01%，振幅7.14%，量比2.61。来凯医药-B今日主力资金净流入436.7万元，上一交易日主力净流出240.9万元。该股近5个交易日上涨1.73%，主力资金累计净流出240.4万元；近20日主力资金累计净流出150.6万元，其中净流出天数为11日。该股主力净额占比0.07%，港股市场排名136/2714。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114161640a4c253db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114161640a4c253db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"1130056406","title":"港股生物医药股集体走高！百奥赛图-B涨超11%，来凯医药-B涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130056406","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130056406?lang=zh_cn&edition=full","pubTime":"2026-01-14 09:43","pubTimestamp":1768354999,"startTime":"0","endTime":"0","summary":"1月14日，港股生物医药股集体走高，$百奥赛图-B(02315)$涨超11%，$来凯医药-B(02105)$、$宜明$昂科(02216)$-B(01541)$涨超5%，$微创$机器人(300024)$-B(02252)$涨超4%，$启明医疗-B(02500)$、$华领医药-B(02552)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c007f4db8ce2cc0ef142359e6d915978","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","02315","02216","BK1161","BK1617","02105","BK1583","BK1574","02552","BK1191","02500","02252","BK1100"],"gpt_icon":0},{"id":"2603521486","title":"港股异动 | 来凯医药-B(02105)涨近7% LAE118新药临床试验申请获FDA受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2603521486","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603521486?lang=zh_cn&edition=full","pubTime":"2026-01-14 09:34","pubTimestamp":1768354491,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，来凯医药-B(02105)早盘涨近7%，截至发稿，涨5.88%，报14.23港元，成交额934.24万港元。消息面上，1月14日， 来凯医药宣布，美国食品药品监督管理局（FDA）已经受理LAE118的新药临床试验申请（IND）。LAE118是来凯自主研发的一种新型PI3Kα泛突变选择性抑制剂，用于治疗PIK3CA突变的实体瘤患者。PI3Kα突变在乳腺癌、结直肠癌、肺癌、子宫内膜癌和其它癌症患者中较为常见。目前全球已获批的PI3Kα抑制剂对突变型没有选择性， 因对野生型有很强的活性而耐受性较差，且易产生耐药性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c007f4db8ce2cc0ef142359e6d915978","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02105","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.laekna.com","stockEarnings":[{"period":"1week","weight":-0.0688},{"period":"1month","weight":-0.0765},{"period":"3month","weight":0.0883},{"period":"6month","weight":-0.3721},{"period":"1year","weight":0.4226},{"period":"ytd","weight":-0.0921}],"compareEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0124},{"period":"6month","weight":0.0552},{"period":"1year","weight":0.2789},{"period":"ytd","weight":0.0545}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"来凯医药有限公司是一家主要从事癌症、肝脏疾病及肥胖症创新疗法的发现、开发及商业化的投资控股公司。该公司尚处于研发阶段。该公司的在研管线产品包括Afuresertib（LAE002）、LAE001、LAE109、LAE111、LAE112、LAE113、LAE117、LAE118、LAE119、LAE102、LAE103、LAE104、LAE105、LAE106、LAE107、LAE120、LAE123等。Afuresertib是一种三磷酸腺苷（ATP）竞争性AKT抑制剂。LAE001是雄激素合成抑制剂，可同时抑制CYP17A1及CYP11B2。该公司主要在中国、美国、欧洲、韩国等市场开展业务。","exchange":"SEHK","name":"来凯医药-B","nameEN":"LAEKNA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"来凯医药-B(02105)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供来凯医药-B(02105)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"来凯医药-B,02105,来凯医药-B股票,来凯医药-B股票老虎,来凯医药-B股票老虎国际,来凯医药-B行情,来凯医药-B股票行情,来凯医药-B股价,来凯医药-B股市,来凯医药-B股票价格,来凯医药-B股票交易,来凯医药-B股票购买,来凯医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"来凯医药-B(02105)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供来凯医药-B(02105)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}